VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

<< Previous

Bullboard Posts

Post by jopatcloon Sep 22, 2024 2:49pm

73 Views

Post# 36235495

Take Heart Conference 💖Oct 4, 1:00 PM - Oct 5, 2:00 pm👀

Interesting on website see logo Ventripoint and Ascend Cardiovascular https://theohhf.org/take-heart-conference/ on Linkedin Ollie Hinkle Heart and see TECHNOLOGY & RESEARCH

01 Prediction: Ventripoint A.I. 3D Heart Chambers Model

Brian Soriano MD, FASE | Cardiologist, Associate Professor, Cardiology, and Adjunct Associate

Professor, Radiology, Seattle Children’s Hospital

Wow, I can't wait for our annual virtual interactive educational conference! Join heart families and leading clinicians to share, collaborate, and innovate for courage, confidence, and hope. Register now to attend live event or for later viewing! HeartConference2024 VirtualEvent HeartHealth